New SEC Form D filing
Aptevo Therapeutics Inc., 2026-08-26
A new SEC Form D private-offering notice from Seattle, WA, a $3,472,683 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical stage biotechnology company developing bispecific and trispecific antibody immunotherapies for cancer
Filed 2026-08-26Filed to raise $3,472,683First money in 2026-08-12Raised so far $3,472,683HQ (as filed) Seattle, WASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified aptevotherapeutics.com↗Named in the filing 8 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR sourceThe Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.